Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus

Title
Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus
Authors
Keywords
-
Journal
DRUG SAFETY
Volume 33, Issue 2, Pages 87-100
Publisher
Springer Nature
Online
2010-01-20
DOI
10.2165/11319130-000000000-00000

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started